{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:46:57Z","timestamp":1791704817975,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2025KY073"],"award-info":[{"award-number":["2025KY073"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103480"],"award-info":[{"award-number":["82103480"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LQ22H090018"],"award-info":[{"award-number":["LQ22H090018"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.tranon.2026.103021","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T16:34:26Z","timestamp":1788626066000},"page":"103021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cellular subpopulation remodeling and biphasic molecular dynamics in glioma recurrence: a multi-omics analysis and diagnostic markers screening using liquid biopsy samples"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0995-4639","authenticated-orcid":false,"given":"Yulong","family":"Lan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2928-0184","authenticated-orcid":false,"given":"Xun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tranon.2026.103021_bib0001","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10571-025-01642-1","article-title":"From classical to emerging biomarkers of brain and central nervous system tumors. An evidence-based review with a focus on gliomas","volume":"46","author":"Ortega","year":"2026","journal-title":"Cell. Mol. Neurobiol."},{"issue":"24","key":"10.1016\/j.tranon.2026.103021_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262412162","article-title":"Glioblastoma-a contemporary overview of epidemiology, classification, pathogenesis, diagnosis, and treatment: a review article","volume":"26","author":"Kr\u00f3likowska","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl 2","key":"10.1016\/j.tranon.2026.103021_bib0003","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016-2020","volume":"25","author":"Ostrom","year":"2023","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.103021_bib0004","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2214\/AJR.17.18003","article-title":"Multiparametric MRI for differentiation of radiation necrosis from recurrent tumor in patients with treated glioblastoma","volume":"210","author":"Nael","year":"2018","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.tranon.2026.103021_bib0005","doi-asserted-by":"crossref","unstructured":"Louis D.N, Perry A., Wesseling P., Brat D.J, Cree I.A, Figarella-Branger D., Hawkins C., Ng H.K, Pfister S.M, Reifenberger G. The 2021 WHO classification of tumors of the central nervous system: a summary neuro oncol. 2021;23 (8):1231-1251. doi:10.1093\/neuonc\/noab106.","DOI":"10.1093\/neuonc\/noab106"},{"issue":"1","key":"10.1016\/j.tranon.2026.103021_bib0006","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s12035-025-05634-6","article-title":"Circulating vesicular biomarkers in Alzheimer's disease: from mechanistic insights to clinical applications","volume":"63","author":"Patil","year":"2026","journal-title":"Mol. Neurobiol."},{"issue":"8","key":"10.1016\/j.tranon.2026.103021_bib0007","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrclinonc.2013.110","article-title":"Liquid biopsy: monitoring cancer-genetics in the blood","volume":"10","author":"Crowley","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.tranon.2026.103021_bib0008","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3390\/cells15030309","article-title":"Decoding glioblastoma through liquid biopsy: molecular insights and clinical prospects","volume":"15","author":"Wasiak","year":"2026","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.tranon.2026.103021_bib0009","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.annonc.2025.02.005","article-title":"ctDNA detection in cerebrospinal fluid and plasma and mutational concordance with the primary tumor in a multicenter prospective study of patients with glioma","volume":"36","author":"Cabezas-Camarero","year":"2025","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.103021_bib0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s40478-023-01613-x","article-title":"Decoding key cell sub-populations and molecular alterations in glioblastoma at recurrence by single-cell analysis","volume":"11","author":"Wang","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"issue":"3","key":"10.1016\/j.tranon.2026.103021_bib0011","first-page":"215","article-title":"Unveiling the diagnostic potential of platelet-to-lymphocyte ratio and HALP score in newly diagnosed breast cancer: a step toward early detection","volume":"21","author":"Ayan","year":"2025","journal-title":"Eur. J. Breast. Health"},{"issue":"1","key":"10.1016\/j.tranon.2026.103021_bib0012","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10238-026-02057-y","article-title":"The safety and efficacy of bispecific T-cell engagers (TCEs) in patients with glioma","volume":"26","author":"Robat-Jazi","year":"2026","journal-title":"Clin. Exp. Med."},{"issue":"7","key":"10.1016\/j.tranon.2026.103021_bib0013","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41571-018-0003-5","article-title":"Current state of immunotherapy for glioblastoma","volume":"15","author":"Lim","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.103021_bib0014","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s40478-025-02031-x","article-title":"Endothelial transdifferentiation of glioma stem cells: a literature review","volume":"13","author":"Buruiana","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"issue":"12","key":"10.1016\/j.tranon.2026.103021_bib0015","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s43018-022-00475-x","article-title":"A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targets","volume":"3","author":"Wang","year":"2022","journal-title":"Nat. Cancer"},{"issue":"13","key":"10.1016\/j.tranon.2026.103021_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111420","article-title":"Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastoma","volume":"40","author":"Qazi","year":"2022","journal-title":"Cell Rep."},{"issue":"12","key":"10.1016\/j.tranon.2026.103021_bib0017","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/j.cell.2022.04.038","article-title":"Glioma progression is shaped by genetic evolution and microenvironment interactions","volume":"185","author":"Varn","year":"2022","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.tranon.2026.103021_bib0018","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70693","article-title":"The nexus of stemness, telomere stability, and metabolic reprogramming in glioblastoma: foundations of tumor persistence and targets for intervention","volume":"7","author":"Sung","year":"2026","journal-title":"MedComm"},{"issue":"6","key":"10.1016\/j.tranon.2026.103021_bib0019","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1111\/cas.15773","article-title":"Single-cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug-resistance mechanisms of recurrent glioblastoma","volume":"114","author":"Wu","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.tranon.2026.103021_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2026.116591","article-title":"Single-cell systems network and machine learning dissection of ferroptosis in recurrent glioblastoma highlights astrocytic ZFP36 as a therapeutic hub for network medicine repurposing","volume":"237","author":"Kishinani","year":"2026","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.tranon.2026.103021_bib0021","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/S1470-2045(23)00005-0","article-title":"Current drug development and trial designs in neuro-oncology: report from the first American society of clinical oncology and society for neuro-oncology clinical trials conference","volume":"24","author":"Rahman","year":"2023","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.tranon.2026.103021_bib0022","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/cncr.34711","article-title":"Top advances of the year: Neuro-oncology","volume":"129","author":"Barden","year":"2023","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.tranon.2026.103021_bib0023","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14061384","article-title":"Deciphering tumour heterogeneity: from tissue to liquid biopsy","volume":"14","author":"Gilson","year":"2022","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.tranon.2026.103021_bib0024","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3171\/jns.2005.102.5.0897","article-title":"Independent predictors of morbidity after image-guided stereotactic brain biopsy: a risk assessment of 270 cases","volume":"102","author":"McGirt","year":"2005","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.tranon.2026.103021_bib0025","doi-asserted-by":"crossref","DOI":"10.1177\/11769351221076062","article-title":"Liquid biopsy: a distinctive approach to the diagnosis and prognosis of cancer","volume":"21","author":"Hirahata","year":"2022","journal-title":"Cancer Inform."},{"issue":"1","key":"10.1016\/j.tranon.2026.103021_bib0026","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12916-017-0840-6","article-title":"Emerging concepts in liquid biopsies","volume":"15","author":"Perakis","year":"2017","journal-title":"BMC Med."},{"issue":"9","key":"10.1016\/j.tranon.2026.103021_bib0027","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.3390\/biomedicines11092371","article-title":"Advances on liquid biopsy analysis for glioma diagnosis","volume":"11","author":"Skouras","year":"2023","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.tranon.2026.103021_bib0028","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ccell.2023.02.019","article-title":"Transcriptome analysis reveals tumor microenvironment changes in glioblastoma","volume":"41","author":"Hoogstrate","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.tranon.2026.103021_bib0029","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.devcel.2021.12.007","article-title":"Quiescent human glioblastoma cancer stem cells drive tumor initiation, expansion, and recurrence following chemotherapy","volume":"57","author":"Xie","year":"2022","journal-title":"Dev. Cell"},{"issue":"1","key":"10.1016\/j.tranon.2026.103021_bib0030","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1038\/s41467-022-31981-2","article-title":"Integrin \u03b13\u03b21 promotes vessel formation of glioblastoma-associated endothelial cells through calcium-mediated macropinocytosis and lysosomal exocytosis","volume":"13","author":"Bae","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tranon.2026.103021_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218216","article-title":"Tumor microenvironment in glioblastoma: the central role of the hypoxic-necrotic core","volume":"639","author":"Bayona","year":"2026","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.tranon.2026.103021_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-022-01259-6","article-title":"Targeting integrin pathways: mechanisms and advances in therapy","volume":"8","author":"Pang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"11","key":"10.1016\/j.tranon.2026.103021_bib0033","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.21037\/tlcr-2025-520","article-title":"Subtype-specific RNA sequencing using micro-dissection revealed extracellular matrix alterations as key factors in lung adenocarcinoma invasion","volume":"14","author":"Yuan","year":"2025","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.tranon.2026.103021_bib0034","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/bs.irn.2020.03.006","article-title":"Proteins of Wnt signaling pathway in cancer stem cells of human glioblastoma","volume":"151","author":"Shevchenko","year":"2020","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.tranon.2026.103021_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2026.112795","article-title":"RUVBL1 supports TIP60-associated proteasome adaptation and temozolomide resistance in glioblastoma","volume":"148","author":"Kong","year":"2026","journal-title":"Cell Signal."},{"issue":"37","key":"10.1016\/j.tranon.2026.103021_bib0036","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M116.738047","article-title":"The A-kinase anchoring protein (AKAP) glycogen synthase kinase 3\u03b2 interaction protein (GSKIP) regulates \u03b2-catenin through its interactions with both protein kinase A (PKA) and GSK3\u03b2","volume":"291","author":"Dema","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"7873","key":"10.1016\/j.tranon.2026.103021_bib0037","first-page":"583","article-title":"Highly accurate protein structure prediction with Alpha","volume":"596","author":"Jumper","year":"2021","journal-title":"Fold Nat."},{"issue":"7873","key":"10.1016\/j.tranon.2026.103021_bib0038","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41586-021-03828-1","article-title":"Highly accurate protein structure prediction for the human proteome","volume":"596","author":"Adler","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.tranon.2026.103021_bib0039","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12943-024-02140-6","article-title":"Artificial intelligence alphafold model for molecular biology and drug discovery: a machine-learning-driven informatics investigation","volume":"23","author":"Guo","year":"2024","journal-title":"Mol. Cancer"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:29:49Z","timestamp":1791703789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326003578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":39,"alternative-id":["S1936523326003578"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103021","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cellular subpopulation remodeling and biphasic molecular dynamics in glioma recurrence: a multi-omics analysis and diagnostic markers screening using liquid biopsy samples","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103021"}}